Through strategic partnership and co-developments, TreeFrog Therapeutics will help cell therapy players to secure cell production and quality, fasten clinical development and facilitate market access.
Articles about TreeFrog Therapeutics:
- December 30, 2019 How can we live longer? 5 European startups extending our lifespans
- October 7, 2019 10 European biotech startups to look out for in 2019 and beyond
- September 9, 2019 TreeFrog Therapeutics receives €3 million in grant funding to accelerate the mass production of pluripotent stem cells
- May 16, 2019 Bordeaux-based startup TreeFrog Therapeutics raises over €7 million for its tech to mass produce stem cells